Just breathe
At Shastrah, we leverage cutting-edge eNose technology to transform early cancer detection. Our innovative diagnostic tool employs state-of-the-art AI and machine learning to enhance our non-invasive breath test, identifying cancer biomarkers with exceptional accuracy and efficiency. This groundbreaking approach offers numerous benefits, including:
01
Non-Invasive Testing
Our breath test eliminates the need for uncomfortable and invasive procedures, making it easier and more acceptable for patients.
02
Immediate Results
The point-of-care testing provides results on the spot, enabling prompt decision-making and reducing the anxiety associated with waiting for lab results.
03
Cost-Effective
By minimizing the need for lab-based analyses and extensive medical infrastructure, our technology significantly reduces the overall cost of cancer screening.
04
High Accuracy
Leveraging advanced AI and machine learning algorithms, our diagnostic tool ensures high sensitivity and specificity in detecting cancer biomarkers.
05
Enhanced Accessibility
Designed to be user-friendly and portable, our technology is ideal for deployment in underserved and remote communities, ensuring broader access to early cancer detection.
In the US, Cancer is the second most common cause of death
United States
17 million survivors, 600,000 annual deaths.
Global
19.3 million new cases, 10 million deaths (2020).
Developing Regions
57% of global cases, 70% of global deaths. (7 mil)
Developed Regions
High prevalence, 30% lower mortality than developing regions. (3 mil)
BOOK AN APPOINTMENT
Let’s talk
CONTACT
Contact
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam hendrerit metus ex, id ullamcorper massa accumsan volutpat.
Call Us Now
+62 985436782
Mail Us Now
